Antiapoptotic role of PPARβ in keratinocytes via transcriptional control of the Akt1 signaling pathway

Molecular Cell

Volumn 10, Issue 4, 2002, Pages 721-733

  Di Po, Nicolas ^a   Tan, Nguan Soon ^a   Michalik, Liliane ^a   Wahli, Walter ^a   Desvergne, Béatrice ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHOSPHOINOSITIDE DEPENDENT KINASE 1; GELATINASE B; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN LINKED KINASE; ISOENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PHOSPHOTRANSFERASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; 3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE; AKT1 PROTEIN, HUMAN; CELL RECEPTOR; GROWTH PROMOTOR; INTEGRIN-LINKED KINASE; MESSENGER RNA; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANOIKIS; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; KERATINOCYTE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WOUND CLOSURE; WOUND HEALING; ANIMAL; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; WESTERN BLOTTING;

ANIMALIA;

ANIMALS; ANOIKIS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; MICE; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036771764     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00646-9     Document Type: Article

References (29)

1. Barak Y., Liao D., He W., Ong E.S., Nelson M.C., Olefsky J.M., Boland R., Evans R.M. Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc. Natl. Acad. Sci. USA. 99:2002;303-308.
2. Chen W.S., Xu P.Z., Gottlob K., Chen M.L., Sokol K., Shiyanova T., Roninson I., Weng W., Suzuki R., Tobe K.et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15:2001;2203-2208.
3. Cho H., Thorvaldsen J.L., Chu Q., Feng F., Birnbaum M.J. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276:2001;38349-38352.
4. Desvergne B., Wahli W. Ppars. nuclear control of metabolism Endocr. Rev. 20:1999;649-688.
5. Dreyer C., Keller H., Mahfoudi A., Laudet V., Krey G., Wahli W. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of peroxisome proliferator-activated receptors. Biol. Cell. 77:1993;67-76.
6. Filippa N., Sable C.L., Hemmings B.A., Van Obberghen E. Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation. Mol. Cell. Biol. 20:2000;5712-5721.
7. Flynn P., Wongdagger M., Zavar M., Dean N.M., Stokoe D. Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival. Curr. Biol. 10:2000;1439-1442.
8. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:1994;619-626.
9. Gerondakis S., Grossmann M., Nakamura Y., Pohl T., Grumont R. Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function. transgenics and knockouts Oncogene. 18:1999;6888-6895.
10. Jost M., Class R., Kari C., Jensen P.J., Rodeck U. A central role of Bcl-X(L) in the regulation of keratinocyte survival by autocrine EGFR ligands. J. Invest. Dermatol. 112:1999;443-449.
11. Khwaja A., Rodriguez-Viciana P., Wennstrom S., Warne P.H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:1997;2783-2793.
12. Michalik L., Desvergne B., Tan N.S., Basu-Modak S., Escher P., Rieusset J., Peters J.M., Kaya G., Gonzalez F.J., Zakany J.et al. Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)alpha and PPARbeta mutant mice. J. Cell Biol. 154:2001;799-814.
13. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell. Signal. 14:2002;381-395.
14. Novak A., Hsu S.C., Leung-Hagesteijn C., Radeva G., Papkoff J., Montesano R., Roskelley C., Grosschedl R., Dedhar S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc. Natl. Acad. Sci. USA. 95:1998;4374-4379.
15. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
16. Park B.H., Breyer B., He T.C. Peroxisome proliferator-activated receptors. roles in tumorigenesis and chemoprevention in human cancer Curr. Opin. Oncol. 13:2001;78-83.
17. Patel L., Pass I., Coxon P., Downes C.P., Smith S.A., Macphee C.H. Tumor suppressor and anti-inflammatory actions of PPARγ agonists are mediated via upregulation of PTEN. Curr. Biol. 11:2001;764-768.
18. Peters J.M., Lee S.S., Li W., Ward J.M., Gavrilova O., Everett C., Reitman M.L., Hudson L.D., Gonzalez F.J. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta). Mol. Cell. Biol. 20:2000;5119-5128.
19. Ptasznik A., Prossnitz E.R., Yoshikawa D., Smrcka A., Traynor-Kaplan A.E., Bokoch G.M. A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3,4,5-trisphosphate formation in chemoattractant-stimulated human neutrophils. J. Biol. Chem. 271:1996;25204-25207.
20. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175:1992;1181-1194.
21. Segrelles C., Ruiz S., Perez P., Murga C., Santos M., Budunova I.V., Martinez J., Larcher F., Slaga T.J., Gutkind J.S.et al. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene. 21:2002;53-64.
22. Silverman N., Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2001;2321-2342.
23. Sonoda Y., Matsumoto Y., Funakoshi M., Yamamoto D., Hanks S.K., Kasahara T. Anti-apoptotic role of focal adhesion kinase (FAK). Induction of inhibitor-of-apoptosis proteins and apoptosis suppression by the overexpression of FAK in a human leukemic cell line, HL-60. J. Biol. Chem. 275:2000;16309-16315.
24. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:2001;463-516.
25. Tan N.S., Michalik L., Noy N., Yasmin R., Pacot C., Heim H., Flühmann B., Desvergne B., Wahli W. Critical roles of PPARβ/δ in keratinocyte response to inflammation. Genes Dev. 15:2001;3263-3277.
26. Welch H., Eguinoa A., Stephens L.A., Hawkins P.T. Protein kinase B and Rac are activated in parallel within a phosphatidylinositide 3OH-kinase-controlled signaling pathway. J. Biol. Chem. 273:1998;11248-11256.
27. Wingender E., Chen X., Hehl R., Karas H., Liebich I., Matys V., Meinhardt T., Pruss M., Reuter I., Schacherer F. Transfac. an integrated system for gene expression regulation Nucleic Acids Res. 28:2000;316-319.
28. Wu C., Dedhar S. Integrin-linked kinase (ILK) and its interactors. a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes J. Cell Biol. 155:2001;505-510.
29. Wu X., Senechal K., Neshat M.S., Whang Y.E., Sawyers C.L. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. USA. 95:1998;15587-15591.